Dindolyl Methane, or DIM as it’s commonly known as, is a very popular supplement for bodybuilders as well as other individuals interested in enhancing the growth of their muscles. Recent research has shown that DIM could pose health hazards. For example, DIM can cause serious liver damage when consumed in excess. Another risk is kidney damage, which can lead to kidney failure. The potential long-term health risks associated with DIM cause many athletes and bodybuilders ask the question: should I supplement my diet with a supplement with DIM?
Most people use diindolylmethane as a supplement to increase the production of testosterone. Testosterone is believed to function as an androgen, which means that it can cause hormonal changes in tissues. Studies have shown DIM to mimic the effects both of testosterone and other hormones. Since men produce more testosterone than women do, some manufacturers have added diindolylmethane into their products in order to increase their competitiveness in male circles. The idea is that men will respond to a product which replicates the effects of testosterone naturally produced.
Many companies market DIM as a tumor suppressor. Diindolylmethane is a fact that it does reduce tumor growth in laboratory animals, however the animals were given the drug, not orally. In order for humans to experience the same result diindolylmethane needs to be taken in large doses for a long duration. The animals studied did not show symptoms of cancer for several years. However, they all developed liver diseases due to consuming too much diindolylmethane. For a thorough glimpse of the way DIM works in the body, you should contact a medical practitioner.
According to the US National Institute of Environmental Health Safety and Security, the only way to demonstrate that DIM is effective in treating breast cancer is to conduct an experiment in which cells from healthy breast cancer cells are exposed to high doses of diindolylmethane for a long period of time. As with any chemical there are pros and cons associated with using it. Its advantages include the capability to mimic hormones. This allows you to create insulin that can stop cancer cell growth. Cons include the fact that diindolylmethane produces a damaging chemical called DMSO. Read more about dim diindolylmethane supplement now.
One of the most popular claims about diindolylmethane’s usage as treatment for various illnesses is that it is an anti-cancer, natural, antibacterial, and anti-fungal agent. These claims were rejected by the National Institute of Health after an exhaustive review of supporting data. According to the Institute of Chemical Technology, there was no research conducted to prove this claim. The Institute of Chemical Safety, through an in-depth examination of the safety profile of the firestone concluded that the data offered by pharmaceutical companies on the benefits of diindolylmethane to humans were not entirely reliable.
In the May 2021 edition of the Journal of Toxicology and Environmental Health, van der Goes, et al. pointed out numerous potential hazards related to the use of diindolylmethane, including allergic reactions to the skin, asthma attacks, dizziness, headaches, and respiratory problems. The daily dose recommended for this chemical, which is approximately one tenth to one teaspoon was 0.2 milligrams. It isn’t clear what the concentration level is when it is compounded with other compounds. This substance is not safe because it has not been thoroughly tested.
The abstract of the view demonstrates the use of diindolylmethane in cancer treatment is based on the notion that intracellular inhibition of pyruvate metabolism by flavenoids can be inhibited and prevents accumulation of Oxalates and pyruvate-derived metabolites in the renal tubule cells. Metabiplicate toxicology studies on the drug have not proven that this chemical could cause overdose. The Food and Drug Administration approved the substance as a prescription drug in June 1996. According to the FDA the manufacturer of firestone Tincture is currently completing two major tests in Europe and the United States.
The abstract of the view also demonstrates the use of diindolylmethane in the treatment of cancer is based on the principle of inhibiting intracellular inhibition by flavenoids of pyruvate metabolism , and thus preventing the accumulation of adenine and oxalates in the renal tubule cells. However, the drug metabiplicate toxicity studies did not present convincing evidence that consumption of this chemical can cause an overdose. In June 1996, the Food and Drug Administration approved the drug as a prescription drug. According to the FDA the manufacturer of firestone tincture is in the process of completing two major trials – one in Europe and another in the United States. According to FDA, the FDA states that the maker of firestone Tincture is conducting two major trials in Europe as well as one in the United States.